AT&T’s 5G, Broadband Growth Strategies Lead Analyst To Bullish Outlook
AT&T Inc (NYSE: T) recently reported mixed results for its fourth quarter, amid stiff competition from Verizon Commu
7 AMD Analysts Deep Dive Into Q4 Print: ‘Expectations Are Reaching A Fever Pitch’
Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) declined in early trading on Wednesday, after the Santa Clara, California-based company repo
Plug Power Stock Is Surging: What’s Going On?
Roth MKM analyst Craig Irwin on Wednesday upgraded Plug Power from Neutral to Buy and raised the price target from $4.50 to $9, citing continued progress of the company's hydrogen plant in Georgia.
Block Focuses On Increasing Efficiency And Profitability, Says Bullish Analyst
Shares of Block Inc (NYSE: SQ) rose in premarket trading on Tuesday, after struggling for several weeks on weak Bitcoin prices.
Microsoft Q2 Earnings Preview: Artificial Intelligence, Gaming, More Key Items To Watch
A look at the expectations from analysts for Microsoft's Q2 earnings report and key items for investors to watch.
Colgate’s Bright Smile: Analyst Envisions Upswing In 2024 Guidance With Ample Growth Opportunities
Raymond James analyst upgrades Colgate-Palmolive to Outperform and announces $91 price target. Strong Q4 earnings and 2024 outlook cited.
AbbVie’s Transformational 2023, Analyst Anticipates Growth in 2024 Amid Competitive Pressures
AbbVie's growth outlook in 2024 as William Blair upgrades, highlighting strong performance in Humira erosion management, strategic acquisitions, and a 3.8% dividend yield.
Hershey’s Pricing Power Continues To Sweeten Sales, Drive Growth: Analyst
Shares of Hershey Co (NYSE: HSY) rose in premarket trading on Monday.
The candy company’s market share and volume trends have improved significantly in recent months, according to Bernstein.
Analyst Highlights ‘Rock Solid’ Data For Vera Therapeutics’ Kidney Disease-Targeted Atacicept, Upgrades To Strong Buy
72-week data from Vera Therapeutics' Phase 2b ORIGIN trial on atacicept for IgA nephropathy. Analysts upgrade stock to Strong Buy, citing impressive efficacy and low-risk profile.
This Radcom Analyst Believes Stock Is Poised For A ‘Break Out’ Once Telco Recovers
Shares of Radcom Ltd (NASDAQ: RDCM) were climbing in early trading on Thursday.
The Paramus, New Jersey-based company is playing a role in helping solve technical issues that are slowing 5G transitions, according to Needham.